Skip to main navigation Skip to search Skip to main content

Transmitted drug resistance and antiretroviral treatment outcomes in non-subtype B HIV-1-infected patients in south east asia

  • Praphan Phanuphak
  • , Sunee Sirivichayakul
  • , Awachana Jiamsakul
  • , Somnuek Sungkanuparph
  • , Nagalingeswaran Kumarasamy
  • , Man Po Lee
  • , Thira Sirisanthana
  • , Pacharee Kantipong
  • , Christopher Lee
  • , Adeeba Kamarulzaman
  • , Mahiran Mustafa
  • , Rossana Ditangco
  • , Tuti Merati
  • , Winai Ratanasuwan
  • , Thida Singtoroj
  • , Rami Kantor

Research output: Contribution to journalArticleResearchpeer-review

Abstract

BACKGROUND: We compared treatment outcomes of transmitted drug resistance (TDR) in patients on fully or partially sensitive drug regimens. METHODS: Factors associated with survival and failure were analyzed using Cox proportional hazards and discrete time conditional logistic models. RESULTS: TDR, found in 60 (4.1%) of 1471 Asian treatment-naive patients, was one of the significant predictors of failure. Patients with TDR to >1 drug in their regimen were >3 times as likely to fail compared to no TDR. CONCLUSIONS: TDR was associated with failure in the context of non-fully sensitive regimens. Efforts are needed to incorporate resistance testing into national treatment programs.

Original languageEnglish
Pages (from-to)74-79
Number of pages6
JournalJournal of Acquired Immune Deficiency Syndromes
Volume66
Issue number1
DOIs
Publication statusPublished - 1 May 2014
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • ART outcome
  • HIV-1
  • South East Asia
  • transmitted drug resistance

Cite this